Rockville, Feb. 16, 2023 (GLOBE NEWSWIRE) -- As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global autoinjectors market is valued at US$ 59.04 billion in 2023 and is predicted to expand at a CAGR of 16% from 2023 to 2033.
An autoinjector is a syringe that has a spring-charged needle and a pre-charged amount of medication. The device activates and administers a precise quantity of medication when slipped into the body. Autoinjectors are commonly used in migraine therapy, medical and emergency procedures, and the self-administration of epinephrine to prevent anaphylaxis.
Auto-injectors have several advantages, including a reduction in the prevalence of needle-related anxiety disorders, a decreased likelihood of accidental needle sticks, consistent dosage quality, and an improvement in efficacy. A severe, possibly fatal allergic response to food, medications, latex, and stings from hymenopteran stingers is known as anaphylaxis.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8346
Report Attributes | Details |
| Forecast Period | 2023 - 2033 |
| Value Projection (2032) | US$ 260.45 Billion |
| Growth Rate (2022-2032) | 16 % CAGR |
| No. of Pages | 170 pages |
| No. of Tables | 30 Tables |
| No. of Figures | 127 Figures |
Key Takeaways from Market Study
- The global market for autoinjectors is projected to reach US$ 260.45 billion by 2033.
- Germany’s market is predicted to expand at a CAGR of 13% during the forecast period.
- Demand for autoinjectors in China is expected to rise at an impressive CAGR of 21.5% during the forecast period.
- Use of autoinjectors for the treatment of rheumatoid arthritis is predicted to rise at a high CAGR of 16.5% from 2023 to 2033.
“Rapid technological advancements and improved autoinjector designs are expected to drive market growth over the coming years,” says a Fact.MR analyst.
Winning Strategy
Key market players are adopting several marketing strategies such as mergers, acquisitions, partnerships, new product launches, and more to maintain their market position and earn more revenue.
- Halozyme Therapeutics, Inc. declared the acquisition of Antares Pharma, Inc. in April 2022.
- The first autoinjector for prefilled syringes with integrated connection was released in October 2021, according to prominent medical equipment firm Ypsomed.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8346
Competitive Landscape
To gain a large client base and earn more revenue shares, key players in the autoinjectors market are developing advanced home-use autoinjectors, and needle-free devices & therapies. Along with this, they are also adopting market strategies such as mergers, collaborations, partnerships, regional expansion, and more.
Fact.MR report reveals detailed information regarding winning strategies such as local supply, product standards, supply chain management, quality control, and more adopted by leading companies in the autoinjectors market to earn more.
- The Qfinity autoinjector platform, a straightforward, reusable, and cost-effective solution for subcutaneous (SC) drug self-administration, was introduced by Jabil Healthcare, a branch of Jabil Inc., in May 2022.
- Stevanato Group S.p.A. inked an exclusive contract for its Aidaptus auto-injector in May 2022 with Owen Mumford Ltd., one of the top producers and innovators of medical devices.
Key Segments of Autoinjectors Industry Research
- By Disease :
- Rheumatoid Arthritis
- Anaphylaxis
- Multiple Sclerosis
- Cardiovascular Disorders
- Diabetes
- By Type :
- Disposable Autoinjectors
- Reusable Autoinjectors
- By Route of Administration :
- Subcutaneous
- Intramuscular
- By Type of Molecule :
- Monoclonal Antibodies
- Peptides, Proteins
- Small Molecules
- By End User :
- Home Care Settings
- Hospitals & Clinics
- Ambulatory Care Settings
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Get Full Access of Complete Report:
https://www.factmr.com/checkout/8346
Key Questions Covered in the Autoinjectors Market Report
- What is the projected value of the Autoinjectors Market in 2023?
- At what rate will the global Autoinjectors Market grow until 2033?
- Which are the factors hampering the growth in the Autoinjectors Market?
- Which region is expected to lead in the global Autoinjectors Market during 2023 to 2033?
- Which are the factors driving the Autoinjectors Market during the forecast period?
- What is the expected market value of the Autoinjectors Market during the forecast period?
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global autoinjectors market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.
The study divulges essential insights on the market on the basis of disease (rheumatoid arthritis, anaphylaxis, multiple sclerosis, cardiovascular disorders, diabetes), type (disposable autoinjectors, reusable autoinjectors), route of administration (subcutaneous, intramuscular), type of molecule (monoclonal antibodies, peptides, proteins, small molecules), and end user (home care settings, hospitals & clinics, ambulatory care settings), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Prefilled Auto Injectors Market: Expanding at a high-value CAGR of 15%, the global prefilled auto injectors market is extrapolated to attain a valuation of US$ 17 billion by 2033-end, up from its current size of US$ 4.2 billion.
Syringes Market: The global syringes market is set to enjoy a valuation of US$ 17,889 Million in 2022 and further expand at a CAGR of 4.2% to reach US$ 26.995.6 Million by the end of 2032.
Chromatography Syringes Market: The global chromatography syringes market was valued at around US$ 73.75 Million in 2021, which amounts to close to 1% share of overall chromatography instrument demand. Sales of chromatography syringes are projected to accelerate at a CAGR of 6% to top US$ 140 Million by 2032.
Single-Use Syringe Market: Increased prevalence of chronic diseases, increased healthcare spending, growing lifestyle-related disorders, and other critical factors are driving factor of Single-Use Syringe, it is forecasted that the market will show a CAGR of 8 to 9% in the forecast period 2021-2031.
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Connect to Author: Mr. Shambhu Nath Jha
Email : shambhu@factmr.com
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | YouTube
